Blood test showdown: can a simple change cut unnecessary antibiotics in the ICU?

NCT ID NCT07211620

Recruiting now Knowledge-focused Sponsor: Semmelweis University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 31 times

Summary

This study tests whether looking at how a blood marker (procalcitonin) changes over time is better than a single measurement for deciding when to start antibiotics in critically ill patients. About 250 adults in the ICU with a suspected infection will be randomly assigned to one of two approaches. The goal is to reduce unnecessary antibiotic use while keeping patients safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Saint Margaret's Hospital
NOT_YET_RECRUITING

Budapest, 1032, Hungary

Contact Phone: •••-•••-•••• Email: •••••@•••••
Semmelweis University, Department of Intensive Therapy
RECRUITING

Budapest, 1082, Hungary

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INFECTION SEPSIS